Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Prostatic Neoplasms, Castration-Resistant
×
darolutamide
×
Clear all
Filters
3
NCT04157088
2023-08-04
DaroAcT
Bayer
Phase 2
Terminated
30 enrolled
25 charts